MK-0812 is a Selective CCR2 Antagonist
Inhibition of monocyte and macrophage function by targeting chemokine receptors represents an attractive strategy for therapeutic intervention in inflammatory diseases. Blockade of CCR2 on whole blood monocytes was demonstrated ex…